Device, method and system for diagnosing, monitoring and predicting chronic health conditions through urine biomarkers

Abstract

A device, system and method for measuring and monitoring analyte concentrations in urine. The device is a cassette comprising two or more hormone or metabolite fluorometric or colorimetric assays, one of which can quantify urine dilution or concentration relative to population standards. The cassette can accommodate multiple lateral flow and/or dry chemistry assays, wherein the fluorometric or colorimetric results are readable quantitatively by a countertop or handheld reader and the results are normalized by the urine concentration measurement. In preferred embodiments, the analytes relate to symptoms of menopausal transition and have dynamic ranges sufficient to handle the known analyte fluctuations during such transition.

Dependencies are inferred from the claim text.